Aggregate Spend for States
Provides an overview of state-specific aggregate spend laws governing reporting and compliance for transfers of value to healthcare professionals. Covers […]
Provides an overview of state-specific aggregate spend laws governing reporting and compliance for transfers of value to healthcare professionals. Covers […]
An overview of state consumer privacy laws, including GDPR-inspired regulations and health data acts like Washington’s My Health, My Data
Learn about FDA regulations for prescription drug advertisements, including risk disclosure requirements, fair balance, and differences between broadcast and print
This module details AKS prohibitions on remuneration to HCPs, safe harbors, and high-risk activities. Participants will review enforcement cases and
Provides an overview of the FCA, including false claim standards, whistleblower provisions, penalties, and its impact on the pharmaceutical industry.
This training provides an overview of FDA regulations (21 CFR Part 99) governing the dissemination of information about unapproved/new uses
This training covers state expansions of HIPAA, focusing on California’s CMIA and Texas’ TMRPA. It outlines requirements for communications, safeguards,
This training covers PDMA rules for drug sample distribution, including practitioner validation, inventory tracking, and FDA reporting for thefts/losses. Suggested
This module explains U.S. pharmacovigilance systems, emphasizing adverse event (AE) reporting timelines, serious AE criteria, and FDA’s FAERS database. Participants
Covers the Sunshine Act’s reporting requirements for payments to HCPs (Section 6002) and drug sample disclosures (Section 6004). Suggested For: